Trial Details

COMPLETED
Basic Information
Clinical ID c3911
Identifier NCT01340053
Trial Title A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable Bowel Syndrome (IBS-C)
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Constipation Predominant Irritable Bowel Syndrome
Interventions DRUG: RDX5791
Participant Information
Sponsor Ardelyx
City San Diego
Country/Region United States
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2
Time Information
Start Date 2011-05
Primary Completion Date 2011-12
Completion Date 2012-02